Eray ATALAY, Gül GÜRSOY, Fatih GÜNGÖR, Seyit Murat BAYRAM, Aslı Araz GÜNGÖR

The relationship of mean platelet volume with retinopathy in type 2 diabetes mellitus

Background/aim: Patients with diabetes mellitus have an increased risk of developing micro- and macrovascular complications. Retinopathy is one of the most important complications of diabetes whose pathophysiological cause has not yet been determined. One candidate may be platelet volume. In this study we aimed to investigate the association between mean platelet volume and diabetic retinopathy. Materials and methods: Mean platelet volume levels were investigated in type 2 diabetic patients with and without retinopathy, and in healthy participants. After reclassifying our diabetics in terms of the presence or absence of hypertension and hyperlipidemia, we compared their mean platelet volumes. We then checked to see if the mean platelet volume correlated with hemoglobin A1c and body mass index. Results: The mean platelet volume levels were higher in all diabetic patients, and they were highest in diabetics with retinopathy. The mean platelet volume levels were not different in diabetic patients with and without hypertension or hyperlipidemia. Moreover, the mean platelet volume levels did not correlate with hemoglobin A1c or body mass index. Conclusion: We think that platelets may play a role in diabetic retinopathy. We can also say that, in diabetic patients, hypertension, hyperlipemia, obesity, and control of diabetes were not related to mean platelet volume.

PDF

___

1. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001; 22: 1561-1571.
2. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2, production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 21: 443-460.
3. Kodiatte TA, Manikyam UK, Rao SB, Jadish TM, Reddy M, Lingaiah HK, Lakshmaih M. Mean platelet volume in Type 2 diabetes mellitus. J Lab Physicians 2012; 4: 5-9.
4. Jindal S, Gupta S, Gupta R, Kakar A, Singh HV, Gupta K, Singh S. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology 2011; 16: 86-89.
5. Demirtunç R, Duman D, Başar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complicat 2009; 23: 89-94.
6. Bavbek N, Kargılı A, Kaftan O, Karakurt F, Koşar A, Akçay A. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy? Clin Appl Thromb Hemost 2007; 13: 391-397.
7. Mustand JF, Packham MA. Platelets and diabetes mellitus. New Engl J Med 1984; 311: 665-667.
8. Hekimsoy Z, Payzin B, Örnek T, Kandoğan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complicat 2004; 18: 173-176.
9. Vinocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992; 41: 26-31. 10. Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H. Normal range of mean platelet volume in healthy subjects: Insight from
a large epidemiologic study. Thromb Res 2011; 128: 358-360. 11. Ünübol M, Ayhan M, Güney E. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets 2012; 23: 475-480.
12. Turgutalp K, Özhan O, Akbay E, Tombak A, Tiftik N, Özcan T, Yılmaz S, Helvacı İ, Kiykim A. Mean platelet volume and related factors in patients at different stages of diabetic nephropathy: a preliminary study. Appl Thromb Hemost 2014; 20: 190-195.
13. Papanas N, Symonidis G, Maltezos E, Mavridisd G, Karavageli E, Vosnakidis TH, Lakasas G. Mean platelet volume with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
14. Shah B, Sha D, Xie D, Mohler ER, Berger JS. The relationship between diabetes, metabolic syndrome and platelet activity as measured by mean platelet volume. Diabetes Care 2012; 35: 1074-1078.
15. Keskin S, Gürler M, Temeloğlu M, Çelebi A, Alicanoğlu R, Ekizoğlu I. Relation between mean platelet volume and risk factors for coronary heart disease. Türkiye Klinikleri J Med Sci 2006; 26: 380-384 (article in Turkish with an abstract in English).
16. Zdrojewski Z, Lizakowski S, Raszeja-Specht A, Skibowska A, Rutkowski B. Influence of spontaneous thrombocyte aggregation on progression of glomerular disease. Nephron 2002; 92: 36-42.
17. Yarlioglues M, Kaya MG, Ardic I, Dogdu O, Kasapkara H, Gunter E, Akpek M, Kalay N, Doğan A, Ozdoğru I et al. Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Pres 2011; 20: 92-97.
18. Bath PMW, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrin 1996; 7: 431-436.
19. Xiao W, Huang Y, Dong J, Zhang X, Hu J. Relationship between platelet volume indices with macrovascular and peripheral neuropathy complications in type 2 diabetic patients. J Diabetes 2014; 6: 298-303.
20. Papanas N, Mavridis G, Karavageli E, Symeonidis G, Maltezoa E. Paripheral neuropathy is associated with increased mean platelet volume in type 2 diabetic patients. Platelets 2005; 16: 498-499.
21. Hekimsoy Z, Payzin B, Örnek T, Kandoğan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complicat 2004;
18: 173-176. 22. Sharpe PC, Thrink T. Mean platelet volume in diabetes mellitus. Q J Med 1993; 86: 739-742.
23. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409- 1411.
24. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80-84.
25. Hendra TJ, Oswald GA, Yudkin YS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pr 1988; 5: 63-69.
26. Lalouschek W, Lang W, Müler M; Vienna Stroke study Group. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry. Stroke 2001; 32: 2860-2866.
27. Bennett PH. The diagnosis of diabetes: new international classification and diagnostic criteria. Annu Rev Med 1983; 34: 295-309.
28. Mancia G, De Backer G Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G. Management of arterial hypertension of the European Society of Hypertension, European Society of Cardiology, 2007 guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187.
29. National Cholesterol Education Program. Detection, evaluation and treatment of high blood cholesterol in adults. Circulation 2002: 106: 3145-3421.
30. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Diabetic retinopathy. Position statement. Clinical Practice Recommendations 2003. Diabetes Care 2003; 26 (Suppl): S99-S102.
31. Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H. Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study. Thromb Res 2011; 128: 358-360.
32. Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol 2003; 92: 1362-1365.
33. Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J 2008; 49: 114-116.
34. Coban E, Bostan F, Özdoğan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17: 67- 69.
35. Coban E, Kucuktağ S, Basyiğit S. Platelet activation in subjects with impaired glucose tolerance. Platelets 2007; 18: 591-594.
36. Shimodaire M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, Nakayama T. Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects. J Diabetes Investig 2014; 5: 66-71.
37. Shimodaire M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, Nakayama T. Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals. Cardiovasc Diabetol 2013; 12: 12-14.
38. Erikçi AA, Muhçu M, Dündar O, Öztürk A. Could mean platelet volume be a predictive marker for gestational diabetes. Hematology 2008; 13: 46-48.
39. Martyn CN, Matthews DM, Popp-Snijders C, Tucker J, Ewing DJ, Clarke BF. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes. Diabetes Care 1986; 9: 36-39.
40. Watanabe Y, Kawada M, Kobayashi B. Effect of insulin on murine megacaryocytopoiesis in a liquid culture system. Cell Struct Funct 1987; 12: 311-316.
41. Guthikonda S, Alviar CL, Vaduganathan M, Arıkan M, Tellez A, DeLao T, Granada JF, Dong JF, Keiman NS, Lev EL. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 743-749.
42. Jones RL, Paradise C, Peterson CM. Platelet survival in patients with diabetes mellitus. Diabetes 1981; 30: 486-489.
43. Martin JF. The relationship between megacaryocyte ploidy and platelet volume. Blood Cells 1989; 15: 108-117.
44. Dindar S, Cinemre H, Sengül E, Annakaya AN. Mean platelet volume is associated with glycemic control and retinopathy in patients with type 2 diabetes mellitus. West Indian Med J 2013; 62: 519-523.
45. Betteridge D, Zahavi J. Jones NAG, Shine B, Kakar VV, Galton DJ. Platelet function in diabetes mellitus in relationship to complications, glycosylated hemoglobin and serum lipoproteins. Eur J Clin Invest 1981; 11: 273-277.
46. Zhong ZL, Han M, Chen S. Risk factors associated with retinal neovascularisation of diabetic retinopathy in type 2 diabetes mellitus. Int J Ophtalmol 2011; 4: 182-185.
47. Tuzcu AE, Arıca S, İlhan N, Dağlıoğlu M, Coşkun M, İlhan O, Üstün I. Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes. Graef Arch Clin Exp 2014: 252: 237-240.
48. Ntaios G, Gürer O, Faouzi M, Aubert C, Michael P. Hypertension is an independent indicator of mean platelet volume in patients with acute ischemic stroke. Intern Med J 2011; 41: 691-695.
49. Cao X, Xie X, Zhou J, Yang P, Wang Y, Chen Z. Increased platelet volume in a general population with prehypertension: a cross-sectional study of 80 545 participants from China. Hypertens Res 2012; 35: 903-908.
50. Coban E, Adanir H, Bilgin D. The association of mean platelet volume levels with hypertensive retinopathy. Platelets 2008; 19: 115-118.
51. Bulur S, Önder HI, Aslantaş Y, Ekinozu I, Kılıç AÇ, Yalçın S, Bulur S, Özhan H. Relation between indices of end-organ damage and mean platelet volume in hypertensive patients. Blood Coagul Fibrin 2012; 23: 367-369.
52. Bakovic D, Pivac N, Eterovic D, Palada I, Valıc Z, PaukovicSekulic B, Dujic Z. Changes in platelet size and spleen volume in response to selective and non-selective beta adrenoreceptor blockade in hypertensive patients. Clin Exp Pharmacol Physiol 2009; 36: 441-446.
53. Çelik T, Yüksel UC, Iyisoy A, Kursaklıoğlu H, Özcan O, Kılıç S, Özmen N, Işık E. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol. Int J Cardiol 2007; 116: 206-211.
54. Demirtunç R, Duman D, Başar M. Effect of doxazocin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study. Clin Drug Investig 2007; 27: 435-441.
55. Jagroop IA, Mikhailidis DP. Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens 2000; 14: 581-585.
56. Verdoia M, Schaffer A, Barbieri L, Cassetti E, Nardin M, Bellomo G, Marino P, Sinigaglia F, De Luca G; Novara Atherosclerosis Study (NAS) group. Diabetes, glucose control and mean platelet volume: a singlecentre cohort study. Diabetes Res Clin Pract 2014; 104: 288-294.
57. Nufuez A, Gomez A, Zalba LR, Monton M, Jimenez A, Velasco S, Lopez-Blaya A, Uriarte VC, Casado S, Lopez-Farre A. Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan. J Renin-Angio-Aldo S 2000; 1: 175- 179.
58. Bath P, Algert C, Chapman N, Neal B. PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622-626.
59. Tschoepe D, Roesen P, Schwippert B, Gries FA. Platelets in diabetes. The role of hemostatic regulation in atherosclerosis. Semin Thromb Haemost 1993; 19: 122-128.
60. Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13: 301-306.
61. Sivri N, Tekin G, Yatla K, Aksoy Y, Senen K, Yetkin E. Statins decrease mean platelet volume irrespective of cholesterol lowering effect. Kardiol Pol 2013; 71: 1042-1047.
62. Mayer J, Eller T, Brauer P, Sollader EM, Schafer RM, Keller F, Kochsiek K. Effects of long term treatment with lovastatin on the clotting system and blood platelets. Ann Hematol 1992; 64: 196-201.
63. Bath PMW, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrin 1996; 7: 431-436.
64. Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Haemost 1991; 17: 433-438.
65. Vinocour PD, Lopes-Virella MF, Laimins M, Colwell JA. Effect of insulin treatment in streptozocin induced diabetic rats on in vitro platelet function and plasma Von Willebrand factor activity and factor VIII related antigen. J Lab Clin Med 1985; 106: 319-325.
66. Vinocour PD, Kinlough-Rathbone RL, Mustard JF. Pathways responsible for platelet hypersensitivity in rats with diabetes. II spontaneous diabetes in BB Wistar rats. J Lab Clin Med 1986; 107: 154-158.
67. Tschoepe D, Ostermann H, Huebinger A, Ziegler D, Wiefels K, Gries FA. Elevated platelet activation in type 1 diabetics with chronic complications under long-term near normoglycemic control. Haemostasis 1990; 20: 93-98.
68. Coban E, Özdoğan M, Yazıcıoğlu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2006; 59: 981- 982.
69. Muscari A, De Pascalis S, Cenni A, Ludovico C, Castaldini N, Antonelli S, Bianchi G, Magalotti D, Zoli M. Determinants of mean platelet volume in an elderly population: relevance of body fat, blood glucose and ischemic electrocardiographic changes. Thromb Haemost 2008; 99: 1079-1084.